|
Volumn 22, Issue 11, 2002, Pages 981-984
|
Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ANTINEOPLASTIC ANTIMETABOLITE;
AZACITIDINE;
BUTYRIC ACID DERIVATIVE;
DRUG DERIVATIVE;
PROTEIN P16INK4A;
ARTICLE;
BIOSYNTHESIS;
CELL CULTURE;
CELL CYCLE;
CELL DIVISION;
DRUG EFFECT;
DRUG POTENTIATION;
GENE EXPRESSION;
HUMAN;
MULTIPLE MYELOMA;
PATHOLOGY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
WESTERN BLOTTING;
ANTIMETABOLITES, ANTINEOPLASTIC;
AZACITIDINE;
BLOTTING, WESTERN;
BUTYRATES;
CELL CYCLE;
CELL DIVISION;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
DRUG SYNERGISM;
GENE EXPRESSION;
HUMANS;
MULTIPLE MYELOMA;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TUMOR CELLS, CULTURED;
|
EID: 0036830966
PISSN: 10002588
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|